US Bancorp DE Sells 1,413 Shares of Agilent Technologies, Inc. (NYSE:A)

US Bancorp DE reduced its position in Agilent Technologies, Inc. (NYSE:A) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,996 shares of the medical research company’s stock after selling 1,413 shares during the quarter. US Bancorp DE’s holdings in Agilent Technologies were worth $8,597,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of A. Farther Finance Advisors LLC lifted its holdings in shares of Agilent Technologies by 11.9% during the third quarter. Farther Finance Advisors LLC now owns 1,944 shares of the medical research company’s stock valued at $288,000 after acquiring an additional 207 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of Agilent Technologies by 1.5% during the third quarter. Janney Montgomery Scott LLC now owns 135,581 shares of the medical research company’s stock valued at $20,131,000 after acquiring an additional 2,049 shares during the period. Opes Wealth Management LLC bought a new position in shares of Agilent Technologies during the third quarter valued at $202,000. National Pension Service lifted its holdings in shares of Agilent Technologies by 10.8% during the third quarter. National Pension Service now owns 702,631 shares of the medical research company’s stock valued at $104,327,000 after acquiring an additional 68,670 shares during the period. Finally, Asset Management One Co. Ltd. lifted its holdings in shares of Agilent Technologies by 1.1% during the third quarter. Asset Management One Co. Ltd. now owns 116,493 shares of the medical research company’s stock valued at $17,297,000 after acquiring an additional 1,284 shares during the period.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $126.36 on Tuesday. The stock has a market capitalization of $36.05 billion, a P/E ratio of 29.05, a P/E/G ratio of 3.59 and a beta of 1.11. Agilent Technologies, Inc. has a 1-year low of $124.16 and a 1-year high of $155.35. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The business has a 50-day moving average price of $140.48 and a two-hundred day moving average price of $139.08.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Equities analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Wall Street Analyst Weigh In

A has been the subject of a number of analyst reports. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Sanford C. Bernstein lowered their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Wells Fargo & Company lowered their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. Citigroup raised their target price on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.